IP77-20: Targeting EphA2 reverses immunotherapy resistance in Basal/Squamous bladder cancer via CCL5-mediated T-cell recruitment
Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!